Related Experiment Video
Updated: Jan 9, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Molecular Mechanisms Driving Metastatic Progression Within the Aged Tumor Microenvironment
Sudhir Kumar1, Jagdish Chand2, Preeti Sharma3
1Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Aging promotes cancer metastasis through the tumor microenvironment (TME). Key factors include cellular senescence, chronic inflammation, and immune decline, creating conditions ripe for cancer spread in older adults.
Area of Science:
- Oncology
- Gerontology
- Immunology
Background:
- Metastasis is the primary cause of cancer mortality, with aging significantly influencing its progression.
- Increasing global life expectancy leads to a rise in cancer incidence and complexity in older adults.
- Understanding the aging tumor microenvironment (TME) is crucial for addressing metastasis in elderly populations.
Purpose of the Study:
- To review the molecular and cellular mechanisms by which the aged TME promotes cancer metastasis.
- To explore the interplay of aging hallmarks like senescence, inflammaging, and immune decline in facilitating metastatic development.
- To discuss emerging therapeutic strategies targeting age-related pro-metastatic factors.
Main Methods:
- Literature review of molecular and cellular mechanisms in the aged TME.
- Analysis of aging hallmarks: cellular senescence, inflammaging, immune senescence, ECM remodeling, and angiogenesis.
- Examination of molecular pathways (e.g., TGF-β, STAT3, MAPK) and aging drivers (e.g., telomere shortening, DNA damage).
Main Results:
- Accumulated senescent cells secrete SASPs, remodeling the ECM and activating pro-metastatic pathways (EMT, invasion).
- Chronic inflammation and immune decline create an immunosuppressive TME, aiding immune evasion.
- Vascular and metabolic changes, including hypoxia, support aggressive cancer growth and metastasis.
- Molecular aging hallmarks contribute to genetic instability, fostering a pro-metastatic stroma.
Conclusions:
- The aged TME presents a complex milieu that significantly enhances cancer metastasis.
- Therapeutic strategies like senolytics, anti-inflammatories, and immune modulation show promise.
- Age-specific models and precision medicine are vital for improving outcomes in elderly cancer patients.
More Related Videos
07:00Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Related Concept Videos
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...